TrialBMJ open2026

Oral oxycodone versus sublingual buprenorphine for postoperative pain control after pelvic exenteration (PROSPER): a pilot, registry-embedded, multi-centre, double-blind, placebo-controlled, randomised controlled trial.

Charlotte Johnstone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.